Novel ocular therapies from new cell sources

Michael O&apos;Connor; Patricia Murphy; Melissa Mangala; Seakcheng Lim

Novel ocular therapies from new cell sources

Michael O'Connor
, Patricia Murphy
, Melissa Mangala
, Seakcheng Lim

School of Medicine

Research output: Contribution to journal › Article

Abstract

Stem cells and their derivatives are being used as a means of understanding ocular disease progression and as a source for transplantation.

Original language	English
Pages (from-to)	8-11
Number of pages	4
Journal	Optometry Pharma
Volume	March
Publication status	Published - 2012

Keywords

blindness
cataract
disease models
human induced pluripotent stem cells
retinal degeneration
stem cells

Cite this

@article{96a9c49d55cd4273a61b88cb78a532ac,

title = "Novel ocular therapies from new cell sources",

abstract = "Stem cells and their derivatives are being used as a means of understanding ocular disease progression and as a source for transplantation.",

keywords = "blindness, cataract, disease models, human induced pluripotent stem cells, retinal degeneration, stem cells",

author = "Michael O\'Connor and Patricia Murphy and Melissa Mangala and Seakcheng Lim",

year = "2012",

language = "English",

volume = "March",

pages = "8--11",

journal = "Optometry Pharma",

issn = "0726-5018",

publisher = "Optometrists Association Australia",

}

TY - JOUR

T1 - Novel ocular therapies from new cell sources

AU - O'Connor, Michael

AU - Murphy, Patricia

AU - Mangala, Melissa

AU - Lim, Seakcheng

PY - 2012

Y1 - 2012

N2 - Stem cells and their derivatives are being used as a means of understanding ocular disease progression and as a source for transplantation.

AB - Stem cells and their derivatives are being used as a means of understanding ocular disease progression and as a source for transplantation.

KW - blindness

KW - cataract

KW - disease models

KW - human induced pluripotent stem cells

KW - retinal degeneration

KW - stem cells

UR - http://handle.uws.edu.au:8081/1959.7/524458

M3 - Article

SN - 0726-5018

VL - March

SP - 8

EP - 11

JO - Optometry Pharma

JF - Optometry Pharma

ER -

Novel ocular therapies from new cell sources

Abstract

Keywords

Other files and links

Fingerprint

Cite this